Hashimoto's thyroiditis
Conditions
Interventions
Experimental group:Western medicine standard treatment + Fuzhengqingying granules
Placebo group:Western medicine standard treatment + Fuzhengqinggall granule simulation agent
Sponsors
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. In line with Western diagnostic standards for Uhashimoto's thyroiditis; 2. Conforming to TCM syndrome differentiation standards; 3. Patients between the ages of 18 and 70, both male and female; 4. Serum thyroid hormone level is normal or low; 5. Informed consent, sign informed consent, and voluntarily take the test.
Exclusion criteria
Exclusion criteria: 1. Those who do not meet the diagnostic criteria and inclusion criteria; 2. Patients with serious primary diseases of cardiovascular, cerebrovascular, liver, kidney and hematopoietic systems, mental patients, tumors or AIDS patients; (1) Abnormal creatinine, blood urea nitrogen > 1.2 times the upper limit of normal value, albuminuria > + (> 30mg/dl/100ml); (2) ALT > 1.5 times the upper limit of normal value; (3) Arrhythmia of clinical significance; 3. Pregnant or lactating women, allergic constitution or abnormal liver function; 4. Combined with hyperthyroidism and high serum thyroid hormone level; 5. Those who do not meet the inclusion criteria, do not use drugs as prescribed, cannot judge the efficacy, or have incomplete data that affect the efficacy or safety evaluation; 6. Subjects who are participating in clinical studies of other drugs; 7. Patients who have used other Chinese medicine or Chinese herbal treatment; 8. People who are allergic to traditional Chinese medicine or to multiple drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Antibody reduction response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Remission time and remission rate of clinical symptoms;Recovery rate of clinical symptoms;Safety evaluation index: incidence of adverse events/reactions;There were 5 types of lymphocytes;aldosterone;Angiotensin I;PCC;adrenocorticotropic hormone;AII;Homocysteine;NO;Superoxide dismutase;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactQue Huafa
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed